Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression-Reference-Cited by-同舟云学术

Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression

Published:2023-12-01 Issue:2 Volume:130 Page:201-212
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Xu Nan,Zhuo Jianyong,Chen Yiyuan,Su Renyi,Chen Huan,Zhang Zhensheng,Lian Zhengxing,Lu Di,Wei Xuyong,Zheng Shusen,Xu Xiao^ORCID,Wang Shuai^ORCID,Wei Qiang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02510-9.pdf

Reference30 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Cao M, Ding C, Xia C, Li H, Sun D, He S, et al. Attributable deaths of liver cancer in China. Chin J Cancer Res. 2021;33:480–9.

3. Khan AA, Liu ZK, Xu X. Recent advances in immunotherapy for hepatocellular carcinoma. Hepatob Pancreat Dis Int. 2021;20:511–20.

4. Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345–62.

5. Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894–905.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of RNA modifications in disease-associated macrophages;Molecular Therapy - Nucleic Acids;2024-12

2. Pipeline for Assessing Tumor Immune Status Using Superplex Immunostaining and Spatial Immune Interaction Analysis;2024-08-26